The Procter & Gamble Company
NYSE:PGHousehold & Personal Products
+$0.53 today
- Market cap
- $394.70B
- Beta
- 0.39
- P/E (TTM)
- 21.9
- EPS (TTM)
- $6.90
- Dividend yield
- 2.82%
Volume 8.43M
Average 9.50M
PG EBITDA
Earnings before interest, taxes, depreciation, and amortization; a proxy for operating profit before non-cash and financing charges.
The Procter & Gamble CompanyNYSE: PG
EBITDA · Q1 FY2027 · quarter ended Sep 2026
EBITDA growth accelerates
Q1 FY2027 EBITDA of $7.06B rose 0.9% year over year, ahead of the -1.3% change in trailing-twelve-month EBITDA. Sequentially, it rose 41.6% from the prior quarter. Over 3 fiscal years it compounded at +3.9% a year.
Context
- EBITDA amounted to 28.1% of revenue in FY2026, down 0.3 pp from a year earlier.
- EBITDA increased in 3 of the last 3 fiscal years.
- FY2026 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether EBITDA reaches the consensus estimate from 16 analysts of $25.35B (+3.8%) for the fiscal year ending Jun 2027, a step up from the +2.1% reported in FY2026.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterSep 2026
- $7.06B+41.6% QoQ
- Last fiscal yearJun 2026
- $24.41B+2.1% YoY
- LTMSep 2026
- $24.48B-1.3% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +0.9% | +1.2% | +0.3 pp |
| 1 year | +2.1% | +3.8% | +1.8 pp |
| 3-year CAGR | +3.9% | +4.1% | +0.2 pp |
| 5-year CAGR | +2.8% | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EBITDA history
USD · from the income statement
- Latest · FY2026
- 24.41B USD
- Year-over-year change
- +2.1%
- 4-year CAGR
- +3.5%
| Period | Period end | EBITDA | YoY change |
|---|---|---|---|
| FY2026 | 2026-06-30 | 24.41B | +2.1% |
| FY2025 | 2025-06-30 | 23.92B | +5.9% |
| FY2024 | 2024-06-30 | 22.58B | +3.7% |
| FY2023 | 2023-06-30 | 21.77B | +2.5% |
| FY2022 | 2022-06-30 | 21.24B | — |
EBITDA vs competitors
How PG compares with its peers on the latest reported figures
- Peers report in different currencies, so EBITDA is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of -1.3% is the 4th highest of 8, against a peer median of -5.3%.
- EBITDA amounts to 27.8% of revenue for PG, versus a peer median of 19.9%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Sep 2026 | $24.48B USD | -1.3% | +3.9% | 27.8% | |
| FY2025 | €11.52B EUR | -11.5% | +2.9% | 22.8% | |
| LTM Sep 2026 | $3.86B USD | -19.7% | +13.0% | 18.1% | |
| LTM Sep 2026 | $3.26B USD | +10.9% | -3.6% | 21.0% | |
| LTM Jun 2026 | $3.19B USD | -15.2% | -0.8% | 19.2% | |
| LTM Sep 2026 | $1.87B USD | +344.4% | -11.7% | 12.2% | |
| LTM Sep 2026 | $1.43B USD | +8.6% | +27.5% | 19.9% | |
| LTM Sep 2026 | $1.29B USD | -5.3% | +16.0% | 20.6% | |
| Peer median (excluding PG) | — | -5.3% | +2.9% | 19.9% | |
Competitors are the stored peer set for PG. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2022 Jun 2022 | FY2023 Jun 2023 | FY2024 Jun 2024 | FY2025 Jun 2025 | FY2026 Jun 2026 |
|---|---|---|---|---|---|
| Revenue | 80.19B | 82.01B | 84.04B | 84.28B | 87.03B |
| Cost of Revenue | 42.16B | 42.76B | 40.85B | 41.16B | 43.36B |
| Gross Profit | 38.03B | 39.25B | 43.19B | 43.12B | 43.67B |
| Gross Margin | 47.4% | 47.9% | 51.4% | 51.2% | 50.2% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 20.22B | 21.11B | 23.31B | 22.67B | 23.92B |
| Operating Expenses | 20.22B | 21.11B | 24.65B | 22.67B | 23.92B |
| Depreciation & Amortization | 2.81B | 2.71B | 2.9B | 2.85B | 3.16B |
| EBITDA | 21.24B | 21.77B | 22.58B | 23.92B | 24.41B |
| EBITDA Margin | 26.5% | 26.5% | 26.9% | 28.4% | 28.1% |
| Operating Income | 17.81B | 18.13B | 18.55B | 20.45B | 19.75B |
| Operating Margin | 22.2% | 22.1% | 22.1% | 24.3% | 22.7% |
| Interest Income | 51M | 307M | 473M | 469M | 430M |
| Interest Expense | 439M | 756M | 925M | 907M | 877M |
| Other Income / Expenses | 182M | 219M | 216M | (284M) | 629M |
| Income Before Tax | 18B | 18.35B | 18.76B | 20.17B | 20.38B |
| Pre-Tax Margin | 22.4% | 22.4% | 22.3% | 23.9% | 23.4% |
| Income Tax Expense | 3.2B | 3.62B | 3.79B | 4.1B | 4.23B |
| Net Income | 14.74B | 14.65B | 14.88B | 15.97B | 16.05B |
| Net Margin | 18.4% | 17.9% | 17.7% | 19.0% | 18.4% |
| EPS (Basic) | 6.00 | 6.07 | 6.18 | 6.67 | 6.75 |
| EPS (Diluted) | 5.81 | 5.90 | 6.02 | 6.51 | 6.62 |
| Weighted Avg Shares | 2.46B | 2.37B | 2.36B | 2.45B | 2.42B |
| Weighted Avg Shares (Diluted) | 2.54B | 2.48B | 2.47B | 2.45B | 2.42B |
The Procter & Gamble Company
NYSE:PG
Intrinsic Alpha fair value
Locked
Current Price
$170.29
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.